nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—MAPK14—mouth—autistic disorder	0.0036	0.00911	CbGeAlD
Nilotinib—MAPK8—forebrain—autistic disorder	0.00357	0.00905	CbGeAlD
Nilotinib—MAPK8—telencephalon—autistic disorder	0.00328	0.00832	CbGeAlD
Nilotinib—EPHB2—digestive system—autistic disorder	0.00314	0.00794	CbGeAlD
Nilotinib—EPHB3—brainstem—autistic disorder	0.00305	0.00773	CbGeAlD
Nilotinib—MAP2K5—hindbrain—autistic disorder	0.00304	0.0077	CbGeAlD
Nilotinib—EPHB3—forebrain—autistic disorder	0.00295	0.00746	CbGeAlD
Nilotinib—CDC42BPB—digestive system—autistic disorder	0.00277	0.00702	CbGeAlD
Nilotinib—EPHB3—telencephalon—autistic disorder	0.00271	0.00686	CbGeAlD
Nilotinib—HCK—forebrain—autistic disorder	0.00271	0.00686	CbGeAlD
Nilotinib—KIT—hindbrain—autistic disorder	0.00269	0.00683	CbGeAlD
Nilotinib—EPHB2—head—autistic disorder	0.00256	0.00648	CbGeAlD
Nilotinib—EPHA4—brainstem—autistic disorder	0.00255	0.00646	CbGeAlD
Nilotinib—MAPK8—digestive system—autistic disorder	0.00251	0.00635	CbGeAlD
Nilotinib—HCK—telencephalon—autistic disorder	0.00249	0.00631	CbGeAlD
Nilotinib—EPHA4—forebrain—autistic disorder	0.00246	0.00623	CbGeAlD
Nilotinib—EPHA8—head—autistic disorder	0.00245	0.00621	CbGeAlD
Nilotinib—CA3—forebrain—autistic disorder	0.00243	0.00616	CbGeAlD
Nilotinib—EPHB2—nervous system—autistic disorder	0.00243	0.00614	CbGeAlD
Nilotinib—KIT—mouth—autistic disorder	0.00236	0.00599	CbGeAlD
Nilotinib—MAPK14—brainstem—autistic disorder	0.00235	0.00595	CbGeAlD
Nilotinib—ABL1—hindbrain—autistic disorder	0.00235	0.00594	CbGeAlD
Nilotinib—EPHB2—central nervous system—autistic disorder	0.00233	0.00592	CbGeAlD
Nilotinib—EPHA8—nervous system—autistic disorder	0.00233	0.00589	CbGeAlD
Nilotinib—MAPK11—head—autistic disorder	0.00228	0.00578	CbGeAlD
Nilotinib—MAPK14—forebrain—autistic disorder	0.00227	0.00575	CbGeAlD
Nilotinib—EPHA4—telencephalon—autistic disorder	0.00226	0.00573	CbGeAlD
Nilotinib—CDC42BPB—head—autistic disorder	0.00226	0.00573	CbGeAlD
Nilotinib—EPHA8—central nervous system—autistic disorder	0.00224	0.00567	CbGeAlD
Nilotinib—CA3—telencephalon—autistic disorder	0.00223	0.00566	CbGeAlD
Nilotinib—EPHA8—cerebellum—autistic disorder	0.00219	0.00554	CbGeAlD
Nilotinib—MAPK11—nervous system—autistic disorder	0.00216	0.00548	CbGeAlD
Nilotinib—CDC42BPB—nervous system—autistic disorder	0.00214	0.00543	CbGeAlD
Nilotinib—EPHA3—head—autistic disorder	0.00214	0.00543	CbGeAlD
Nilotinib—MAPK14—telencephalon—autistic disorder	0.00209	0.00528	CbGeAlD
Nilotinib—MAPK11—central nervous system—autistic disorder	0.00208	0.00527	CbGeAlD
Nilotinib—EPHB3—digestive system—autistic disorder	0.00207	0.00524	CbGeAlD
Nilotinib—CDC42BPB—central nervous system—autistic disorder	0.00206	0.00523	CbGeAlD
Nilotinib—MAPK8—head—autistic disorder	0.00204	0.00518	CbGeAlD
Nilotinib—EPHA6—head—autistic disorder	0.00204	0.00518	CbGeAlD
Nilotinib—MAPK11—cerebellum—autistic disorder	0.00203	0.00515	CbGeAlD
Nilotinib—EPHA3—nervous system—autistic disorder	0.00203	0.00515	CbGeAlD
Nilotinib—CA14—telencephalon—autistic disorder	0.00203	0.00514	CbGeAlD
Nilotinib—CDC42BPB—cerebellum—autistic disorder	0.00202	0.00511	CbGeAlD
Nilotinib—EPHB4—telencephalon—autistic disorder	0.00198	0.00501	CbGeAlD
Nilotinib—EPHB6—forebrain—autistic disorder	0.00197	0.00498	CbGeAlD
Nilotinib—EPHA3—central nervous system—autistic disorder	0.00196	0.00496	CbGeAlD
Nilotinib—MAPK8—nervous system—autistic disorder	0.00194	0.00491	CbGeAlD
Nilotinib—EPHA6—nervous system—autistic disorder	0.00194	0.00491	CbGeAlD
Nilotinib—CA4—hindbrain—autistic disorder	0.00193	0.00488	CbGeAlD
Nilotinib—HCK—digestive system—autistic disorder	0.0019	0.00481	CbGeAlD
Nilotinib—TEK—telencephalon—autistic disorder	0.00189	0.00479	CbGeAlD
Nilotinib—LYN—head—autistic disorder	0.00189	0.00478	CbGeAlD
Nilotinib—MAPK8—central nervous system—autistic disorder	0.00187	0.00473	CbGeAlD
Nilotinib—EPHA6—central nervous system—autistic disorder	0.00187	0.00473	CbGeAlD
Nilotinib—PDGFRA—forebrain—autistic disorder	0.00186	0.00472	CbGeAlD
Nilotinib—CA7—digestive system—autistic disorder	0.00186	0.00471	CbGeAlD
Nilotinib—EPHB2—brain—autistic disorder	0.00185	0.0047	CbGeAlD
Nilotinib—MAPK8—cerebellum—autistic disorder	0.00182	0.00462	CbGeAlD
Nilotinib—EPHB6—telencephalon—autistic disorder	0.00181	0.00458	CbGeAlD
Nilotinib—LYN—nervous system—autistic disorder	0.00179	0.00453	CbGeAlD
Nilotinib—EPHA8—brain—autistic disorder	0.00178	0.0045	CbGeAlD
Nilotinib—TIE1—head—autistic disorder	0.00177	0.00449	CbGeAlD
Nilotinib—MAP2K5—brainstem—autistic disorder	0.00174	0.00441	CbGeAlD
Nilotinib—CA12—eye—autistic disorder	0.00174	0.0044	CbGeAlD
Nilotinib—LYN—central nervous system—autistic disorder	0.00172	0.00436	CbGeAlD
Nilotinib—CA12—forebrain—autistic disorder	0.00172	0.00436	CbGeAlD
Nilotinib—PDGFRA—telencephalon—autistic disorder	0.00171	0.00434	CbGeAlD
Nilotinib—EPHB3—head—autistic disorder	0.00169	0.00427	CbGeAlD
Nilotinib—TIE1—nervous system—autistic disorder	0.00168	0.00426	CbGeAlD
Nilotinib—CSF1R—eye—autistic disorder	0.00166	0.00419	CbGeAlD
Nilotinib—MAPK11—brain—autistic disorder	0.00165	0.00419	CbGeAlD
Nilotinib—CSF1R—forebrain—autistic disorder	0.00164	0.00416	CbGeAlD
Nilotinib—CDC42BPB—brain—autistic disorder	0.00164	0.00415	CbGeAlD
Nilotinib—CA9—digestive system—autistic disorder	0.00163	0.00414	CbGeAlD
Nilotinib—TIE1—central nervous system—autistic disorder	0.00162	0.0041	CbGeAlD
Nilotinib—EPHB3—nervous system—autistic disorder	0.0016	0.00405	CbGeAlD
Nilotinib—CA2—hindbrain—autistic disorder	0.0016	0.00405	CbGeAlD
Nilotinib—MAPK14—digestive system—autistic disorder	0.00159	0.00403	CbGeAlD
Nilotinib—FGR—digestive system—autistic disorder	0.00159	0.00402	CbGeAlD
Nilotinib—CA12—telencephalon—autistic disorder	0.00158	0.00401	CbGeAlD
Nilotinib—TIE1—cerebellum—autistic disorder	0.00158	0.00401	CbGeAlD
Nilotinib—EPHA3—brain—autistic disorder	0.00155	0.00394	CbGeAlD
Nilotinib—HCK—head—autistic disorder	0.00155	0.00393	CbGeAlD
Nilotinib—MAP2K5—telencephalon—autistic disorder	0.00155	0.00392	CbGeAlD
Nilotinib—KIT—brainstem—autistic disorder	0.00154	0.00391	CbGeAlD
Nilotinib—EPHB3—central nervous system—autistic disorder	0.00154	0.0039	CbGeAlD
Nilotinib—BRAF—cerebellum—autistic disorder	0.00152	0.00384	CbGeAlD
Nilotinib—EPHB4—digestive system—autistic disorder	0.00151	0.00382	CbGeAlD
Nilotinib—CSF1R—telencephalon—autistic disorder	0.00151	0.00382	CbGeAlD
Nilotinib—EPHB3—cerebellum—autistic disorder	0.0015	0.00381	CbGeAlD
Nilotinib—MAPK8—brain—autistic disorder	0.00148	0.00375	CbGeAlD
Nilotinib—EPHA6—brain—autistic disorder	0.00148	0.00375	CbGeAlD
Nilotinib—EPHA2—digestive system—autistic disorder	0.00148	0.00375	CbGeAlD
Nilotinib—HCK—nervous system—autistic disorder	0.00147	0.00372	CbGeAlD
Nilotinib—CA6—head—autistic disorder	0.00147	0.00372	CbGeAlD
Nilotinib—PDGFRB—eye—autistic disorder	0.00147	0.00372	CbGeAlD
Nilotinib—HCK—central nervous system—autistic disorder	0.00141	0.00358	CbGeAlD
Nilotinib—EPHA4—head—autistic disorder	0.00141	0.00357	CbGeAlD
Nilotinib—CA2—mouth—autistic disorder	0.0014	0.00355	CbGeAlD
Nilotinib—CA3—head—autistic disorder	0.00139	0.00352	CbGeAlD
Nilotinib—CA1—eye—autistic disorder	0.00137	0.00348	CbGeAlD
Nilotinib—ABL2—cerebellum—autistic disorder	0.00137	0.00348	CbGeAlD
Nilotinib—KIT—telencephalon—autistic disorder	0.00137	0.00347	CbGeAlD
Nilotinib—LYN—brain—autistic disorder	0.00137	0.00346	CbGeAlD
Nilotinib—CA1—forebrain—autistic disorder	0.00136	0.00345	CbGeAlD
Nilotinib—CA7—cerebellum—autistic disorder	0.00135	0.00343	CbGeAlD
Nilotinib—MAP4K1—brain—autistic disorder	0.00135	0.00341	CbGeAlD
Nilotinib—ABL1—brainstem—autistic disorder	0.00134	0.00341	CbGeAlD
Nilotinib—PDGFRB—telencephalon—autistic disorder	0.00134	0.00339	CbGeAlD
Nilotinib—EPHA4—nervous system—autistic disorder	0.00134	0.00338	CbGeAlD
Nilotinib—CA3—nervous system—autistic disorder	0.00132	0.00334	CbGeAlD
Nilotinib—ABL1—eye—autistic disorder	0.00131	0.00332	CbGeAlD
Nilotinib—PDGFRA—digestive system—autistic disorder	0.00131	0.00332	CbGeAlD
Nilotinib—MAPK14—head—autistic disorder	0.0013	0.00329	CbGeAlD
Nilotinib—FGR—head—autistic disorder	0.00129	0.00328	CbGeAlD
Nilotinib—EPHA4—central nervous system—autistic disorder	0.00129	0.00326	CbGeAlD
Nilotinib—TIE1—brain—autistic disorder	0.00128	0.00326	CbGeAlD
Nilotinib—CA3—central nervous system—autistic disorder	0.00127	0.00322	CbGeAlD
Nilotinib—EPHA4—cerebellum—autistic disorder	0.00126	0.00318	CbGeAlD
Nilotinib—CA1—telencephalon—autistic disorder	0.00125	0.00318	CbGeAlD
Nilotinib—UGT1A1—digestive system—autistic disorder	0.00125	0.00316	CbGeAlD
Nilotinib—BRAF—brain—autistic disorder	0.00123	0.00312	CbGeAlD
Nilotinib—MAPK14—nervous system—autistic disorder	0.00123	0.00312	CbGeAlD
Nilotinib—FGR—nervous system—autistic disorder	0.00123	0.00311	CbGeAlD
Nilotinib—EPHB3—brain—autistic disorder	0.00122	0.0031	CbGeAlD
Nilotinib—CA12—digestive system—autistic disorder	0.00121	0.00306	CbGeAlD
Nilotinib—EPHA2—head—autistic disorder	0.00121	0.00306	CbGeAlD
Nilotinib—ABL1—telencephalon—autistic disorder	0.00119	0.00302	CbGeAlD
Nilotinib—CA9—cerebellum—autistic disorder	0.00119	0.00301	CbGeAlD
Nilotinib—MAPK14—central nervous system—autistic disorder	0.00119	0.003	CbGeAlD
Nilotinib—FGR—central nervous system—autistic disorder	0.00118	0.00299	CbGeAlD
Nilotinib—TEK—head—autistic disorder	0.00118	0.00299	CbGeAlD
Nilotinib—MAPK14—cerebellum—autistic disorder	0.00116	0.00294	CbGeAlD
Nilotinib—CSF1R—digestive system—autistic disorder	0.00115	0.00292	CbGeAlD
Nilotinib—EPHA2—nervous system—autistic disorder	0.00115	0.0029	CbGeAlD
Nilotinib—CA14—cerebellum—autistic disorder	0.00113	0.00286	CbGeAlD
Nilotinib—EPHB6—head—autistic disorder	0.00113	0.00285	CbGeAlD
Nilotinib—HCK—brain—autistic disorder	0.00112	0.00285	CbGeAlD
Nilotinib—TEK—nervous system—autistic disorder	0.00112	0.00283	CbGeAlD
Nilotinib—ABL2—brain—autistic disorder	0.00112	0.00283	CbGeAlD
Nilotinib—CA4—brainstem—autistic disorder	0.0011	0.0028	CbGeAlD
Nilotinib—EPHA2—central nervous system—autistic disorder	0.0011	0.00279	CbGeAlD
Nilotinib—CA7—brain—autistic disorder	0.0011	0.00278	CbGeAlD
Nilotinib—EPHB4—cerebellum—autistic disorder	0.0011	0.00278	CbGeAlD
Nilotinib—TEK—central nervous system—autistic disorder	0.00108	0.00272	CbGeAlD
Nilotinib—EPHB6—nervous system—autistic disorder	0.00107	0.0027	CbGeAlD
Nilotinib—PDGFRA—head—autistic disorder	0.00107	0.0027	CbGeAlD
Nilotinib—CA4—forebrain—autistic disorder	0.00107	0.0027	CbGeAlD
Nilotinib—TEK—cerebellum—autistic disorder	0.00105	0.00266	CbGeAlD
Nilotinib—KIT—digestive system—autistic disorder	0.00105	0.00265	CbGeAlD
Nilotinib—EPHB6—central nervous system—autistic disorder	0.00103	0.0026	CbGeAlD
Nilotinib—PDGFRB—digestive system—autistic disorder	0.00102	0.00259	CbGeAlD
Nilotinib—EPHA4—brain—autistic disorder	0.00102	0.00259	CbGeAlD
Nilotinib—CYP2D6—hindbrain—autistic disorder	0.00101	0.00257	CbGeAlD
Nilotinib—PDGFRA—nervous system—autistic disorder	0.00101	0.00256	CbGeAlD
Nilotinib—CA3—brain—autistic disorder	0.00101	0.00255	CbGeAlD
Nilotinib—EPHB6—cerebellum—autistic disorder	0.001	0.00255	CbGeAlD
Nilotinib—CA12—head—autistic disorder	0.000985	0.0025	CbGeAlD
Nilotinib—CA4—telencephalon—autistic disorder	0.00098	0.00248	CbGeAlD
Nilotinib—PDGFRA—central nervous system—autistic disorder	0.000974	0.00247	CbGeAlD
Nilotinib—MAP2K5—head—autistic disorder	0.000963	0.00244	CbGeAlD
Nilotinib—CA1—digestive system—autistic disorder	0.000957	0.00242	CbGeAlD
Nilotinib—PDGFRA—cerebellum—autistic disorder	0.000952	0.00241	CbGeAlD
Nilotinib—MAPK14—brain—autistic disorder	0.000941	0.00238	CbGeAlD
Nilotinib—CSF1R—head—autistic disorder	0.00094	0.00238	CbGeAlD
Nilotinib—FGR—brain—autistic disorder	0.000937	0.00237	CbGeAlD
Nilotinib—CA12—nervous system—autistic disorder	0.000934	0.00237	CbGeAlD
Nilotinib—CA14—brain—autistic disorder	0.000916	0.00232	CbGeAlD
Nilotinib—CA2—brainstem—autistic disorder	0.000915	0.00232	CbGeAlD
Nilotinib—MAP2K5—nervous system—autistic disorder	0.000913	0.00231	CbGeAlD
Nilotinib—ABL1—digestive system—autistic disorder	0.000911	0.00231	CbGeAlD
Nilotinib—CA12—central nervous system—autistic disorder	0.000899	0.00228	CbGeAlD
Nilotinib—EPHB4—brain—autistic disorder	0.000892	0.00226	CbGeAlD
Nilotinib—CA2—eye—autistic disorder	0.000891	0.00226	CbGeAlD
Nilotinib—CSF1R—nervous system—autistic disorder	0.000891	0.00226	CbGeAlD
Nilotinib—CA2—forebrain—autistic disorder	0.000883	0.00224	CbGeAlD
Nilotinib—MAP2K5—central nervous system—autistic disorder	0.000879	0.00223	CbGeAlD
Nilotinib—EPHA2—brain—autistic disorder	0.000875	0.00222	CbGeAlD
Nilotinib—MAP2K5—cerebellum—autistic disorder	0.000859	0.00218	CbGeAlD
Nilotinib—CSF1R—central nervous system—autistic disorder	0.000858	0.00217	CbGeAlD
Nilotinib—TEK—brain—autistic disorder	0.000854	0.00216	CbGeAlD
Nilotinib—KIT—head—autistic disorder	0.000853	0.00216	CbGeAlD
Nilotinib—CSF1R—cerebellum—autistic disorder	0.000838	0.00212	CbGeAlD
Nilotinib—PDGFRB—head—autistic disorder	0.000833	0.00211	CbGeAlD
Nilotinib—EPHB6—brain—autistic disorder	0.000816	0.00207	CbGeAlD
Nilotinib—CA2—telencephalon—autistic disorder	0.000812	0.00206	CbGeAlD
Nilotinib—KIT—nervous system—autistic disorder	0.000809	0.00205	CbGeAlD
Nilotinib—PDGFRB—nervous system—autistic disorder	0.00079	0.002	CbGeAlD
Nilotinib—CA1—head—autistic disorder	0.00078	0.00198	CbGeAlD
Nilotinib—KIT—central nervous system—autistic disorder	0.000779	0.00197	CbGeAlD
Nilotinib—PDGFRA—brain—autistic disorder	0.000774	0.00196	CbGeAlD
Nilotinib—KIT—cerebellum—autistic disorder	0.000761	0.00193	CbGeAlD
Nilotinib—PDGFRB—central nervous system—autistic disorder	0.000761	0.00193	CbGeAlD
Nilotinib—ABCG2—telencephalon—autistic disorder	0.000752	0.00191	CbGeAlD
Nilotinib—CA4—digestive system—autistic disorder	0.000748	0.00189	CbGeAlD
Nilotinib—PDGFRB—cerebellum—autistic disorder	0.000744	0.00188	CbGeAlD
Nilotinib—ABL1—head—autistic disorder	0.000743	0.00188	CbGeAlD
Nilotinib—CA1—nervous system—autistic disorder	0.00074	0.00187	CbGeAlD
Nilotinib—CA12—brain—autistic disorder	0.000714	0.00181	CbGeAlD
Nilotinib—CA1—central nervous system—autistic disorder	0.000712	0.0018	CbGeAlD
Nilotinib—ABL1—nervous system—autistic disorder	0.000704	0.00178	CbGeAlD
Nilotinib—MAP2K5—brain—autistic disorder	0.000698	0.00177	CbGeAlD
Nilotinib—CSF1R—brain—autistic disorder	0.000681	0.00173	CbGeAlD
Nilotinib—ABL1—central nervous system—autistic disorder	0.000678	0.00172	CbGeAlD
Nilotinib—ABL1—cerebellum—autistic disorder	0.000663	0.00168	CbGeAlD
Nilotinib—CA2—digestive system—autistic disorder	0.00062	0.00157	CbGeAlD
Nilotinib—KIT—brain—autistic disorder	0.000618	0.00157	CbGeAlD
Nilotinib—CA4—head—autistic disorder	0.00061	0.00155	CbGeAlD
Nilotinib—PDGFRB—brain—autistic disorder	0.000604	0.00153	CbGeAlD
Nilotinib—CYP2D6—brainstem—autistic disorder	0.000581	0.00147	CbGeAlD
Nilotinib—CA4—nervous system—autistic disorder	0.000578	0.00147	CbGeAlD
Nilotinib—CA1—brain—autistic disorder	0.000566	0.00143	CbGeAlD
Nilotinib—CYP2D6—forebrain—autistic disorder	0.000561	0.00142	CbGeAlD
Nilotinib—CA4—central nervous system—autistic disorder	0.000557	0.00141	CbGeAlD
Nilotinib—CA4—cerebellum—autistic disorder	0.000544	0.00138	CbGeAlD
Nilotinib—ABL1—brain—autistic disorder	0.000538	0.00136	CbGeAlD
Nilotinib—CYP2B6—digestive system—autistic disorder	0.00053	0.00134	CbGeAlD
Nilotinib—CYP2C9—digestive system—autistic disorder	0.000525	0.00133	CbGeAlD
Nilotinib—CYP2D6—telencephalon—autistic disorder	0.000516	0.00131	CbGeAlD
Nilotinib—CA2—head—autistic disorder	0.000506	0.00128	CbGeAlD
Nilotinib—CA2—nervous system—autistic disorder	0.00048	0.00122	CbGeAlD
Nilotinib—CA2—central nervous system—autistic disorder	0.000462	0.00117	CbGeAlD
Nilotinib—CA2—cerebellum—autistic disorder	0.000451	0.00114	CbGeAlD
Nilotinib—CA4—brain—autistic disorder	0.000442	0.00112	CbGeAlD
Nilotinib—CYP2B6—head—autistic disorder	0.000432	0.00109	CbGeAlD
Nilotinib—ABCG2—cerebellum—autistic disorder	0.000418	0.00106	CbGeAlD
Nilotinib—CYP2B6—nervous system—autistic disorder	0.00041	0.00104	CbGeAlD
Nilotinib—ABCB1—forebrain—autistic disorder	0.000403	0.00102	CbGeAlD
Nilotinib—CYP3A4—digestive system—autistic disorder	0.0004	0.00101	CbGeAlD
Nilotinib—CYP2B6—central nervous system—autistic disorder	0.000394	0.000999	CbGeAlD
Nilotinib—CYP2D6—digestive system—autistic disorder	0.000394	0.000997	CbGeAlD
Nilotinib—ABCB1—telencephalon—autistic disorder	0.000371	0.00094	CbGeAlD
Nilotinib—CA2—brain—autistic disorder	0.000367	0.000929	CbGeAlD
Nilotinib—CYP2C8—brain—autistic disorder	0.000349	0.000885	CbGeAlD
Nilotinib—ABCG2—brain—autistic disorder	0.000339	0.00086	CbGeAlD
Nilotinib—CYP2D6—head—autistic disorder	0.000321	0.000814	CbGeAlD
Nilotinib—CYP2B6—brain—autistic disorder	0.000313	0.000793	CbGeAlD
Nilotinib—CYP3A4—nervous system—autistic disorder	0.000309	0.000784	CbGeAlD
Nilotinib—CYP2D6—nervous system—autistic disorder	0.000304	0.000771	CbGeAlD
Nilotinib—CYP3A4—central nervous system—autistic disorder	0.000298	0.000755	CbGeAlD
Nilotinib—CYP2D6—central nervous system—autistic disorder	0.000293	0.000743	CbGeAlD
Nilotinib—CYP2D6—cerebellum—autistic disorder	0.000287	0.000726	CbGeAlD
Nilotinib—ABCB1—digestive system—autistic disorder	0.000283	0.000717	CbGeAlD
Nilotinib—CYP2D6—brain—autistic disorder	0.000233	0.00059	CbGeAlD
Nilotinib—ABCB1—head—autistic disorder	0.000231	0.000585	CbGeAlD
Nilotinib—ABCB1—nervous system—autistic disorder	0.000219	0.000555	CbGeAlD
Nilotinib—ABCB1—central nervous system—autistic disorder	0.000211	0.000534	CbGeAlD
Nilotinib—ABCB1—cerebellum—autistic disorder	0.000206	0.000522	CbGeAlD
Nilotinib—ABCB1—brain—autistic disorder	0.000167	0.000424	CbGeAlD
Nilotinib—UGT1A1—Metabolism—POMC—autistic disorder	7.67e-06	1.27e-05	CbGpPWpGaD
Nilotinib—FGR—Immune System—IL6—autistic disorder	7.66e-06	1.26e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—APOE—autistic disorder	7.58e-06	1.25e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—APOE—autistic disorder	7.57e-06	1.25e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—LEP—autistic disorder	7.57e-06	1.25e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—STX1A—autistic disorder	7.56e-06	1.25e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—NPAS2—autistic disorder	7.56e-06	1.25e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—PTEN—autistic disorder	7.56e-06	1.25e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—ITGB3—autistic disorder	7.54e-06	1.25e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—PTEN—autistic disorder	7.53e-06	1.24e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—PRKCB—autistic disorder	7.53e-06	1.24e-05	CbGpPWpGaD
Nilotinib—LCK—Hemostasis—HRAS—autistic disorder	7.53e-06	1.24e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—SERPINE1—autistic disorder	7.5e-06	1.24e-05	CbGpPWpGaD
Nilotinib—MAPK14—Innate Immune System—IL6—autistic disorder	7.5e-06	1.24e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—DHFR—autistic disorder	7.48e-06	1.24e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—IGF1—autistic disorder	7.48e-06	1.24e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—IL2—autistic disorder	7.43e-06	1.23e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—autistic disorder	7.38e-06	1.22e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—COMT—autistic disorder	7.38e-06	1.22e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—PTEN—autistic disorder	7.38e-06	1.22e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—APC—autistic disorder	7.36e-06	1.22e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—PIK3CG—autistic disorder	7.36e-06	1.22e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—GSTP1—autistic disorder	7.35e-06	1.21e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—PTEN—autistic disorder	7.34e-06	1.21e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—MAOA—autistic disorder	7.33e-06	1.21e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—SERPINE1—autistic disorder	7.33e-06	1.21e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—TCN2—autistic disorder	7.31e-06	1.21e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—BCL2—autistic disorder	7.3e-06	1.21e-05	CbGpPWpGaD
Nilotinib—BRAF—Disease—MAPK1—autistic disorder	7.29e-06	1.2e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—EGF—autistic disorder	7.27e-06	1.2e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	7.24e-06	1.2e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—IFNG—autistic disorder	7.23e-06	1.19e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—PIK3CG—autistic disorder	7.2e-06	1.19e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—APC—autistic disorder	7.2e-06	1.19e-05	CbGpPWpGaD
Nilotinib—KIT—Immune System—MAPK1—autistic disorder	7.18e-06	1.19e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—CAT—autistic disorder	7.15e-06	1.18e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—PRKCB—autistic disorder	7.13e-06	1.18e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—EGF—autistic disorder	7.12e-06	1.18e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—SERPINE1—autistic disorder	7.1e-06	1.17e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—DHFR—autistic disorder	7.05e-06	1.16e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—HTR2A—autistic disorder	7.04e-06	1.16e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—POMC—autistic disorder	7e-06	1.16e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—PTEN—autistic disorder	6.99e-06	1.16e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—DHFR—autistic disorder	6.99e-06	1.15e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ADA—autistic disorder	6.97e-06	1.15e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—PTEN—autistic disorder	6.96e-06	1.15e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—POMC—autistic disorder	6.86e-06	1.13e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—PIK3CG—autistic disorder	6.84e-06	1.13e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—PIK3CG—autistic disorder	6.83e-06	1.13e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—APC—autistic disorder	6.83e-06	1.13e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—MAPK1—autistic disorder	6.8e-06	1.12e-05	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—HRAS—autistic disorder	6.78e-06	1.12e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—GSTM1—autistic disorder	6.75e-06	1.12e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—PLA2G4A—autistic disorder	6.75e-06	1.12e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—EGF—autistic disorder	6.75e-06	1.12e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—IGF1—autistic disorder	6.74e-06	1.11e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—IL2—autistic disorder	6.73e-06	1.11e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—CYP19A1—autistic disorder	6.72e-06	1.11e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—TSC2—autistic disorder	6.68e-06	1.1e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—IL2—autistic disorder	6.67e-06	1.1e-05	CbGpPWpGaD
Nilotinib—KIT—Disease—MAPK1—autistic disorder	6.63e-06	1.1e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—IGF1—autistic disorder	6.59e-06	1.09e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—APOE—autistic disorder	6.54e-06	1.08e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—LEP—autistic disorder	6.54e-06	1.08e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—POMC—autistic disorder	6.51e-06	1.08e-05	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—HRAS—autistic disorder	6.51e-06	1.07e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—POMC—autistic disorder	6.5e-06	1.07e-05	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—IL6—autistic disorder	6.48e-06	1.07e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—GPX1—autistic disorder	6.47e-06	1.07e-05	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—MAPK1—autistic disorder	6.46e-06	1.07e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—IL2—autistic disorder	6.43e-06	1.06e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—PTGS2—autistic disorder	6.4e-06	1.06e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—SERPINE1—autistic disorder	6.4e-06	1.06e-05	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—HRAS—autistic disorder	6.39e-06	1.06e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—RORA—autistic disorder	6.36e-06	1.05e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—PTEN—autistic disorder	6.33e-06	1.05e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	6.31e-06	1.04e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—MAPK1—autistic disorder	6.28e-06	1.04e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—PTEN—autistic disorder	6.28e-06	1.04e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—SERPINE1—autistic disorder	6.26e-06	1.03e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—IGF1—autistic disorder	6.25e-06	1.03e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—COMT—autistic disorder	6.25e-06	1.03e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—GSTP1—autistic disorder	6.22e-06	1.03e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—MAOA—autistic disorder	6.21e-06	1.03e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—PRKCB—autistic disorder	6.17e-06	1.02e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—MAPK1—autistic disorder	6.15e-06	1.02e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—MAPK1—autistic disorder	6.12e-06	1.01e-05	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—IL6—autistic disorder	6.12e-06	1.01e-05	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—PTGS2—autistic disorder	6.12e-06	1.01e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—IL2—autistic disorder	6.07e-06	1e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—CAT—autistic disorder	6.05e-06	1e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—PTEN—autistic disorder	6.05e-06	9.99e-06	CbGpPWpGaD
Nilotinib—LYN—Immune System—MAPK1—autistic disorder	6e-06	9.91e-06	CbGpPWpGaD
Nilotinib—ABL1—Immune System—MAPK1—autistic disorder	5.97e-06	9.86e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—MTHFR—autistic disorder	5.97e-06	9.86e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—MAOB—autistic disorder	5.96e-06	9.84e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—SERPINE1—autistic disorder	5.94e-06	9.81e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—PIK3CG—autistic disorder	5.9e-06	9.75e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—APC—autistic disorder	5.9e-06	9.75e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	5.89e-06	9.73e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CYP19A1—autistic disorder	5.86e-06	9.68e-06	CbGpPWpGaD
Nilotinib—BRAF—Disease—HRAS—autistic disorder	5.85e-06	9.66e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—EGF—autistic disorder	5.84e-06	9.64e-06	CbGpPWpGaD
Nilotinib—KIT—Immune System—HRAS—autistic disorder	5.77e-06	9.53e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—IL2—autistic disorder	5.75e-06	9.49e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—PLA2G4A—autistic disorder	5.72e-06	9.44e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—GSTM1—autistic disorder	5.72e-06	9.44e-06	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—PTEN—autistic disorder	5.71e-06	9.44e-06	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—MAPK1—autistic disorder	5.68e-06	9.39e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—MAPK1—autistic disorder	5.65e-06	9.34e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—POMC—autistic disorder	5.62e-06	9.28e-06	CbGpPWpGaD
Nilotinib—BRAF—Disease—IL6—autistic disorder	5.6e-06	9.25e-06	CbGpPWpGaD
Nilotinib—LCK—Disease—PTEN—autistic disorder	5.58e-06	9.22e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—APOE—autistic disorder	5.56e-06	9.18e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—TPH2—autistic disorder	5.54e-06	9.15e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CYP19A1—autistic disorder	5.52e-06	9.12e-06	CbGpPWpGaD
Nilotinib—KIT—Immune System—IL6—autistic disorder	5.52e-06	9.12e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—GPX1—autistic disorder	5.47e-06	9.04e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CYP19A1—autistic disorder	5.47e-06	9.04e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—HRAS—autistic disorder	5.46e-06	9.02e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—DPYD—autistic disorder	5.45e-06	9e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—COMT—autistic disorder	5.44e-06	9e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—GSTP1—autistic disorder	5.42e-06	8.95e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—PTEN—autistic disorder	5.41e-06	8.93e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—MAOA—autistic disorder	5.41e-06	8.93e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—IGF1—autistic disorder	5.41e-06	8.93e-06	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—PTEN—autistic disorder	5.34e-06	8.82e-06	CbGpPWpGaD
Nilotinib—KIT—Disease—HRAS—autistic disorder	5.32e-06	8.8e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CAT—autistic disorder	5.27e-06	8.71e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—IL6—autistic disorder	5.22e-06	8.63e-06	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—PTGS2—autistic disorder	5.19e-06	8.58e-06	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—HRAS—autistic disorder	5.19e-06	8.57e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—IL2—autistic disorder	5.18e-06	8.55e-06	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—MAPK1—autistic disorder	5.15e-06	8.51e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	5.14e-06	8.49e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—SERPINE1—autistic disorder	5.13e-06	8.48e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—COMT—autistic disorder	5.13e-06	8.48e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—GSTP1—autistic disorder	5.11e-06	8.44e-06	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—MAPK1—autistic disorder	5.1e-06	8.43e-06	CbGpPWpGaD
Nilotinib—KIT—Disease—IL6—autistic disorder	5.1e-06	8.42e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—MAOA—autistic disorder	5.09e-06	8.42e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—COMT—autistic disorder	5.09e-06	8.4e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—IL2—autistic disorder	5.07e-06	8.37e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CACNA1C—autistic disorder	5.06e-06	8.37e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—GSTP1—autistic disorder	5.06e-06	8.36e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—MTHFR—autistic disorder	5.05e-06	8.35e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—MAOA—autistic disorder	5.05e-06	8.34e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—HRAS—autistic disorder	5.04e-06	8.33e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—PIK3CG—autistic disorder	5.01e-06	8.28e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—GSTM1—autistic disorder	4.98e-06	8.23e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PLA2G4A—autistic disorder	4.98e-06	8.23e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CAT—autistic disorder	4.97e-06	8.21e-06	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—IL6—autistic disorder	4.97e-06	8.2e-06	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—HRAS—autistic disorder	4.93e-06	8.15e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CAT—autistic disorder	4.93e-06	8.14e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—HRAS—autistic disorder	4.92e-06	8.12e-06	CbGpPWpGaD
Nilotinib—LCK—Immune System—MAPK1—autistic disorder	4.92e-06	8.12e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—PTEN—autistic disorder	4.87e-06	8.05e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—IL6—autistic disorder	4.82e-06	7.97e-06	CbGpPWpGaD
Nilotinib—LYN—Immune System—HRAS—autistic disorder	4.81e-06	7.95e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—IL2—autistic disorder	4.8e-06	7.94e-06	CbGpPWpGaD
Nilotinib—ABL1—Immune System—HRAS—autistic disorder	4.79e-06	7.92e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—POMC—autistic disorder	4.77e-06	7.88e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—GPX1—autistic disorder	4.77e-06	7.88e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—PTEN—autistic disorder	4.77e-06	7.88e-06	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—IL6—autistic disorder	4.72e-06	7.8e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—IL6—autistic disorder	4.71e-06	7.78e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—APOE—autistic disorder	4.7e-06	7.77e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—GSTM1—autistic disorder	4.69e-06	7.75e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PLA2G4A—autistic disorder	4.69e-06	7.75e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PLA2G4A—autistic disorder	4.65e-06	7.69e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—GSTM1—autistic disorder	4.65e-06	7.69e-06	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—MAPK1—autistic disorder	4.64e-06	7.67e-06	CbGpPWpGaD
Nilotinib—LYN—Immune System—IL6—autistic disorder	4.61e-06	7.61e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—DHFR—autistic disorder	4.61e-06	7.61e-06	CbGpPWpGaD
Nilotinib—ABL1—Immune System—IL6—autistic disorder	4.59e-06	7.58e-06	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—HRAS—autistic disorder	4.56e-06	7.54e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—HRAS—autistic disorder	4.54e-06	7.5e-06	CbGpPWpGaD
Nilotinib—LCK—Disease—MAPK1—autistic disorder	4.54e-06	7.5e-06	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—PTEN—autistic disorder	4.53e-06	7.48e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—PTEN—autistic disorder	4.52e-06	7.47e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—GPX1—autistic disorder	4.49e-06	7.42e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—GPX1—autistic disorder	4.46e-06	7.36e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—MTHFR—autistic disorder	4.4e-06	7.27e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—MAPK1—autistic disorder	4.4e-06	7.26e-06	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—IL6—autistic disorder	4.37e-06	7.22e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—IL6—autistic disorder	4.35e-06	7.18e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—PIK3CG—autistic disorder	4.24e-06	7.01e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—IL2—autistic disorder	4.15e-06	6.86e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—MTHFR—autistic disorder	4.15e-06	6.85e-06	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—HRAS—autistic disorder	4.13e-06	6.83e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—MTHFR—autistic disorder	4.11e-06	6.79e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—APOE—autistic disorder	4.1e-06	6.77e-06	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—HRAS—autistic disorder	4.1e-06	6.77e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—POMC—autistic disorder	4.04e-06	6.67e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—MAPK1—autistic disorder	3.96e-06	6.54e-06	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—IL6—autistic disorder	3.96e-06	6.54e-06	CbGpPWpGaD
Nilotinib—LCK—Immune System—HRAS—autistic disorder	3.95e-06	6.52e-06	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—IL6—autistic disorder	3.92e-06	6.48e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—PTEN—autistic disorder	3.91e-06	6.46e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—MAPK1—autistic disorder	3.88e-06	6.41e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—APOE—autistic disorder	3.86e-06	6.38e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—APOE—autistic disorder	3.83e-06	6.32e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—PTGS2—autistic disorder	3.81e-06	6.29e-06	CbGpPWpGaD
Nilotinib—LCK—Immune System—IL6—autistic disorder	3.78e-06	6.24e-06	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—HRAS—autistic disorder	3.73e-06	6.16e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PIK3CG—autistic disorder	3.7e-06	6.11e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—MAPK1—autistic disorder	3.68e-06	6.07e-06	CbGpPWpGaD
Nilotinib—LCK—Disease—HRAS—autistic disorder	3.64e-06	6.02e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CYP19A1—autistic disorder	3.61e-06	5.96e-06	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—IL6—autistic disorder	3.57e-06	5.89e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—HRAS—autistic disorder	3.53e-06	5.83e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—POMC—autistic disorder	3.52e-06	5.82e-06	CbGpPWpGaD
Nilotinib—LCK—Disease—IL6—autistic disorder	3.49e-06	5.76e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PIK3CG—autistic disorder	3.48e-06	5.76e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PIK3CG—autistic disorder	3.45e-06	5.71e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—IL6—autistic disorder	3.38e-06	5.58e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—COMT—autistic disorder	3.35e-06	5.54e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GSTP1—autistic disorder	3.34e-06	5.52e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—MAOA—autistic disorder	3.33e-06	5.5e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—PTEN—autistic disorder	3.32e-06	5.48e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—POMC—autistic disorder	3.32e-06	5.48e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—POMC—autistic disorder	3.29e-06	5.43e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CAT—autistic disorder	3.25e-06	5.37e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—PTGS2—autistic disorder	3.22e-06	5.32e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—HRAS—autistic disorder	3.18e-06	5.25e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—MAPK1—autistic disorder	3.18e-06	5.25e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—HRAS—autistic disorder	3.11e-06	5.14e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PLA2G4A—autistic disorder	3.07e-06	5.07e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GSTM1—autistic disorder	3.07e-06	5.07e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—IL6—autistic disorder	3.04e-06	5.03e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—IL6—autistic disorder	2.98e-06	4.92e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—HRAS—autistic disorder	2.95e-06	4.87e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GPX1—autistic disorder	2.94e-06	4.85e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—IL6—autistic disorder	2.82e-06	4.67e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—PTEN—autistic disorder	2.81e-06	4.64e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PTGS2—autistic disorder	2.81e-06	4.64e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—MTHFR—autistic disorder	2.71e-06	4.48e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PTGS2—autistic disorder	2.65e-06	4.37e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PTGS2—autistic disorder	2.62e-06	4.33e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—HRAS—autistic disorder	2.55e-06	4.22e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—APOE—autistic disorder	2.52e-06	4.17e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PTEN—autistic disorder	2.45e-06	4.05e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—IL6—autistic disorder	2.44e-06	4.03e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PTEN—autistic disorder	2.31e-06	3.81e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PTEN—autistic disorder	2.29e-06	3.78e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PIK3CG—autistic disorder	2.28e-06	3.76e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—POMC—autistic disorder	2.17e-06	3.58e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PTGS2—autistic disorder	1.73e-06	2.86e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PTEN—autistic disorder	1.51e-06	2.49e-06	CbGpPWpGaD
